Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) EVP Joseph Konowiecki sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $23.00, for a total transaction of $575,000.00. Following the completion of the transaction, the executive vice president owned 1,128,816 shares in the company, valued at $25,962,768. This trade represents a 2.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Alignment Healthcare Trading Up 2.2%
NASDAQ ALHC traded up $0.50 during mid-day trading on Friday, reaching $23.21. 6,548,273 shares of the stock were exchanged, compared to its average volume of 4,330,164. The stock has a market cap of $4.80 billion, a P/E ratio of 257.84, a P/E/G ratio of 2.93 and a beta of 1.14. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. Alignment Healthcare, Inc. has a one year low of $11.63 and a one year high of $23.87. The stock has a 50 day simple moving average of $18.72 and a 200-day simple moving average of $19.55.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. During the same period last year, the business posted ($0.05) EPS. The business’s revenue was up 33.3% compared to the same quarter last year. On average, analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.
Institutional Investors Weigh In On Alignment Healthcare
Analysts Set New Price Targets
Several brokerages have issued reports on ALHC. Weiss Ratings raised Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a report on Thursday, May 7th. Barclays reduced their target price on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Zacks Research raised Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, April 28th. Finally, UBS Group upped their target price on Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $24.30.
View Our Latest Stock Report on Alignment Healthcare
Alignment Healthcare Company Profile
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Read More
- Five stocks we like better than Alignment Healthcare
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
